Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06068257
Tumor-Derived FGF19
Sponsor: University of Central Florida
View on ClinicalTrials.gov
Summary
Identify and test thresholds, specificity and sensitivity for a potential cancer associated biomarker protein, FGF19, (and associated markers) for detection in human blood in the blood of breast and colorectal in cancer patients, and see if occurs at higher rates than healthy controls
Official title: Translational Utility of Tumor-Derived FGF19 in a Novel Blood-Based Endocrine Suppression Approach
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
210
Start Date
2023-06-06
Completion Date
2025-06
Last Updated
2024-12-06
Healthy Volunteers
Yes
Conditions
Locations (1)
Burnett School Biomedical Sciences
Orlando, Florida, United States